Replies to post #803 on SmurfVA's Random Picks

[Ned Serious]

DARA $.58 - Down 10% after financials and no mention of ODD update. They re-submitted ODD paperwork in November and typically an answer is given in 90 days from what I've read. Although the original submission was a year or so ago. So a verrrryyyyy long delay so far.

-------------------
Provided U.S. Food and Drug Administration (FDA), on November 19, 2013, with additional information requested in support of DARA's request for orphan drug designation for the Company's Phase 2 development asset, KRN5500, for the treatment of painful, treatment-refractory, chronic chemotherapy-induced peripheral neuropathy ("CCIPN").

-------------------

Will be meeting on reverse stock split on Feb 5 and the investor conference/presentation is on Monday.

I am holding for a little while more. Will see what happens in meeting tomorrow and into next week. Am in no hurry to sell, so will wait it out for now.